Therapeutic intervention for Niemann–Pick type C disease must target

Por um escritor misterioso

Descrição

Therapeutic intervention for Niemann–Pick type C disease must target
Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine
Therapeutic intervention for Niemann–Pick type C disease must target
Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management
Therapeutic intervention for Niemann–Pick type C disease must target
Niemann-Pick Disease Type C
Therapeutic intervention for Niemann–Pick type C disease must target
Frontiers Case Report: Be Aware of “New” Features of Niemann–Pick Disease: Insights From Two Pediatric Cases
Therapeutic intervention for Niemann–Pick type C disease must target
Niemann–Pick type C disease: cellular pathology and pharmacotherapy - Wheeler - 2020 - Journal of Neurochemistry - Wiley Online Library
Therapeutic intervention for Niemann–Pick type C disease must target
Niemann-Pick Disease, Type B disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
Therapeutic intervention for Niemann–Pick type C disease must target
Adult‐onset Niemann–Pick disease type C masquerading as spinocerebellar ataxia - Vo - 2022 - Molecular Genetics & Genomic Medicine - Wiley Online Library
Therapeutic intervention for Niemann–Pick type C disease must target
Niemann-Pick type C disease – the tip of the iceberg? A review of neuropsychiatric presentation, diagnosis and treatment, BJPsych Bulletin
Therapeutic intervention for Niemann–Pick type C disease must target
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet
Therapeutic intervention for Niemann–Pick type C disease must target
Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1 - ScienceDirect
de por adulto (o preço varia de acordo com o tamanho do grupo)